MU-380

N/A

Report date: 2025/01/26 16:19:42
NME

Base Information

Drug NameMU-380
Drug Alias Namecheck point kinase 1 inhibitor (University Hospital Brno)MU-380
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCheckpoint kinase 1 inhibitors
TargetsCheckpoint kinase 1
Therapy Area/IndicationsLeukemia, Lymphocytic, Chronic, B-CellNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMasaryk University
China Registration ClassN/A

Develop Information

Active CompaniesMasaryk University
Inactive CompaniesN/A
Active IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A